Feature Channels: Pharmaceuticals

Filters close
Newswise: MEDIA ADVISORY: Cedars-Sinai Experts On Hand to Discuss New Alzheimer’s Drug Now Under Review
Released: 6-Jan-2023 12:25 PM EST
MEDIA ADVISORY: Cedars-Sinai Experts On Hand to Discuss New Alzheimer’s Drug Now Under Review
Cedars-Sinai

The U.S. Food and Drug Administration is poised to make a decision on another new Alzheimer’s disease treatment this week, and experts from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available to explain how the drug works and which patients could benefit from the medication.

Newswise: Roswell Park Study: Chronic Opioid Use Reduced by Limiting Prescribed Opioids After Surgery
Released: 5-Jan-2023 2:30 PM EST
Roswell Park Study: Chronic Opioid Use Reduced by Limiting Prescribed Opioids After Surgery
Roswell Park Comprehensive Cancer Center

Research at Roswell Park Comprehensive Cancer Center shows that putting a three-day limit on opioid prescriptions to treat surgical pain after hospital discharge reduces the number of patients who become chronic opioid users without compromising pain relief or recovery. It also reduces the amount of opioids circulating in the community — a grave concern, given that opioids are implicated in 130 overdose deaths in the U.S. every day.

Released: 5-Jan-2023 1:40 PM EST
Electrochemistry converts carbon to useful molecules
Cornell University

A chemistry collaboration led to a creative way to put carbon dioxide to good – and even healthy – use: by incorporating it, via electrosynthesis, into a series of organic molecules that are vital to pharmaceutical development.

Newswise: Pharmacotyping of childhood leukemia provides a blueprint for ‘true precision medicine’
4-Jan-2023 5:30 PM EST
Pharmacotyping of childhood leukemia provides a blueprint for ‘true precision medicine’
St. Jude Children's Research Hospital

Scientists from St. Jude Children’s Research Hospital performed the largest study yet examining drug sensitivity in childhood acute lymphoblastic leukemia across genomic subtypes and its association with treatment response.

Newswise: Wayne State receives $1.7 million NIH award to understand and address ototoxic side effects of anti-cancer drug
Released: 5-Jan-2023 8:00 AM EST
Wayne State receives $1.7 million NIH award to understand and address ototoxic side effects of anti-cancer drug
Wayne State University Division of Research

Wayne State's Dr. Jamesdaniel received a $1.7 million NIH grant to study cisplatin, a drug that is prescribed to 10 to 20% of cancer patients that causes hearing loss in up to 80% treated with the drug.

Released: 4-Jan-2023 5:35 PM EST
Research provides valuable comparison of anticoagulant drugs
University of Cincinnati

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin for treating cancer-associated thrombosis.

Newswise: Incurable liver disease may prove curable
Released: 4-Jan-2023 4:00 PM EST
Incurable liver disease may prove curable
Sanford Burnham Prebys

Research has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug. The study, published in the Proceedings of the National Academy of Sciences, has the potential to transform treatment for this rare disease and may also have implications for more common diseases.

2-Jan-2023 3:05 PM EST
Can Diet Combined with Drugs Reduce Seizures?
American Academy of Neurology (AAN)

Following a modified Atkins diet high in fat and low in carbohydrates plus taking medication may reduce seizures in people with tough-to-treat epilepsy, according to a study published in the January 4, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: UTSW-led study shows promise for drug to treat upper urinary tract cancers
Released: 4-Jan-2023 12:50 PM EST
UTSW-led study shows promise for drug to treat upper urinary tract cancers
UT Southwestern Medical Center

A team from 15 U.S. medical centers led by UT Southwestern Simmons Cancer Center researchers has performed the first analysis of a potentially game-changing drug to treat upper urinary tract urothelial cancers.

Newswise: SLAS Adds Three New Members to the 2023 Board of Directors
Released: 4-Jan-2023 12:00 PM EST
SLAS Adds Three New Members to the 2023 Board of Directors
SLAS

SLAS, the Society of Laboratory Automation and Screening, announces the addition of three new board members who will carry out three-year terms beginning January 1, 2023.

   
Newswise: Exercise curbs insulin production
Released: 4-Jan-2023 11:05 AM EST
Exercise curbs insulin production
University of Würzburg

Insulin is an essential hormone for humans and many other living creatures. Its best-known task is to regulate sugar metabolism. How it does this job is well understood.

Released: 3-Jan-2023 2:10 PM EST
Stuart Therapeutics, Inc. announces licensing agreement with Aju Pharm Co. Ltd.
Stuart Therapeutics

Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter AJU), for Stuart's clinical stage drug candidate ST-100.

   
Released: 3-Jan-2023 11:05 AM EST
All Patients Should be Screened for Cannabis Use Before Surgery, First U.S. Guidelines Recommend
American Society of Regional Anesthesia and Pain Medicine (ASRA)

All patients undergoing procedures requiring anesthesia should be asked about cannabis use, according to guidelines released by the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine). The first U.S. guidelines on cannabis use in relation to surgery also notes regular use may worsen pain and nausea after surgery and increase the need for opioids.

Not for public release

This news release is embargoed until 2-Jan-2023 5:00 PM EST Released to reporters: 27-Dec-2022 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 2-Jan-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: A step towards precision oncology for patients with metastatic urothelial carcinoma
Released: 30-Dec-2022 12:55 PM EST
A step towards precision oncology for patients with metastatic urothelial carcinoma
Universitätsklinikum Bonn

Dr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University Hospital Bonn (UKB), was awarded the C. E. Alken Prize in recognition of his outstanding scientific uro-oncological work.

Released: 30-Dec-2022 12:10 PM EST
Ketamine found to increase brain noise
National Research University - Higher School of Economics (HSE)

An international team of researchers including Sofya Kulikova, Senior Research Fellow at the HSE University-Perm, found that ketamine, being an NMDA receptor inhibitor, increases the brain's background noise, causing higher entropy of incoming sensory signals and disrupting their transmission between the thalamus and the cortex.

26-Dec-2022 5:05 PM EST
Comparing the cost-effectiveness of treatments for blood clots in cancer patients
UC Davis Health

Clinical scientists with UC Davis and University of Cincinnati perform first-of-its-kind analysis showing a clear difference in cost-effectiveness of medication types for life-threatening condition

Newswise: New Bacterial Therapy Approach to Treat Lung Cancer
Released: 23-Dec-2022 2:05 PM EST
New Bacterial Therapy Approach to Treat Lung Cancer
Columbia University School of Engineering and Applied Science

Columbia Engineering researchers report that they have developed a new experimental pipeline to combine bacterial therapy with current cancer drugs. Their study, which explores resistance to bacterial therapy at the molecular level, has achieved better treatment efficacy without additional toxicity in laboratory models.

Newswise: Cystic fibrosis drug could help treat pneumonia
Released: 22-Dec-2022 4:45 PM EST
Cystic fibrosis drug could help treat pneumonia
Charité - Universitätsmedizin Berlin

Pathogens such as SARS-CoV-2 and pneumococcus can cause severe pneumonia. If the airways then fill with fluid, the patient risks developing acute respiratory distress syndrome.

Newswise: UNC Health Provider Ushers in First FDA-Approved Medication for Eosinophilic Esophagitis
Released: 22-Dec-2022 3:45 PM EST
UNC Health Provider Ushers in First FDA-Approved Medication for Eosinophilic Esophagitis
University of North Carolina Health Care System

Eosinophilic esophagitis (EoE) is an allergic condition of the esophagus that is on the rise throughout the United States. Patients with the condition typically have inflammation throughout their esophagus and trouble swallowing food – known as dysphagia.Without proper treatment, the lining of the esophagus becomes fibrous, and the passage becomes so narrowed, or strictured, that food can lodge in the esophagus, requiring medical attention.



close
3.22654